ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF

Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TENG, Zhu, DRAGHICI, Bogdan, LEBEDEVA, Tatiana, SMIRNOV, Yuriy, DOMINOWSKI, Allison, MORJANA, Nihmat, MAREEVA, Tatiana, BEDZYK, William, SHARMA, Manoj, YAU, Heungyeung, ZHENG, Yi Feng
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TENG, Zhu
DRAGHICI, Bogdan
LEBEDEVA, Tatiana
SMIRNOV, Yuriy
DOMINOWSKI, Allison
MORJANA, Nihmat
MAREEVA, Tatiana
BEDZYK, William
SHARMA, Manoj
YAU, Heungyeung
ZHENG, Yi Feng
description Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disclosed are methods of reducing naloxone or naltrexone interference in opiate assays using the antibodies. L'invention concerne des anticorps qui se lient spécifiquement à la naloxone ou à la naltrexone. L'invention concerne également des conjugués utilisés dans la production des anticorps, ainsi que des procédés de production des anticorps. L'invention concerne de plus des procédés d'utilisation des anticorps dans des dosages directs pour la naloxone ou la naltrexone. L'invention concerne en outre des procédés de réduction de l'interférence de la naloxone ou de la naltrexone dans des dosages d'opiacés à l'aide des anticorps.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2020160199A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2020160199A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2020160199A13</originalsourceid><addsrcrecordid>eNqNirEKwjAUALM4iPoPAedCWkHoGJMXEmjzJHmlbiVInEQL9f9Rgu5OB3e3Zkl6cpWXHV7QA5de85-hAMX16FF1-DElnVA7iOXsgSzqyNHwc0A9KHLoSxkicLIQAM2WrW7pvuTdlxu2N0DKVnl-TnmZ0zU_8msasRGNqI-ibltZH_673oqYNKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF</title><source>esp@cenet</source><creator>TENG, Zhu ; DRAGHICI, Bogdan ; LEBEDEVA, Tatiana ; SMIRNOV, Yuriy ; DOMINOWSKI, Allison ; MORJANA, Nihmat ; MAREEVA, Tatiana ; BEDZYK, William ; SHARMA, Manoj ; YAU, Heungyeung ; ZHENG, Yi Feng</creator><creatorcontrib>TENG, Zhu ; DRAGHICI, Bogdan ; LEBEDEVA, Tatiana ; SMIRNOV, Yuriy ; DOMINOWSKI, Allison ; MORJANA, Nihmat ; MAREEVA, Tatiana ; BEDZYK, William ; SHARMA, Manoj ; YAU, Heungyeung ; ZHENG, Yi Feng</creatorcontrib><description>Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disclosed are methods of reducing naloxone or naltrexone interference in opiate assays using the antibodies. L'invention concerne des anticorps qui se lient spécifiquement à la naloxone ou à la naltrexone. L'invention concerne également des conjugués utilisés dans la production des anticorps, ainsi que des procédés de production des anticorps. L'invention concerne de plus des procédés d'utilisation des anticorps dans des dosages directs pour la naloxone ou la naltrexone. L'invention concerne en outre des procédés de réduction de l'interférence de la naloxone ou de la naltrexone dans des dosages d'opiacés à l'aide des anticorps.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TESTING</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200806&amp;DB=EPODOC&amp;CC=WO&amp;NR=2020160199A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200806&amp;DB=EPODOC&amp;CC=WO&amp;NR=2020160199A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TENG, Zhu</creatorcontrib><creatorcontrib>DRAGHICI, Bogdan</creatorcontrib><creatorcontrib>LEBEDEVA, Tatiana</creatorcontrib><creatorcontrib>SMIRNOV, Yuriy</creatorcontrib><creatorcontrib>DOMINOWSKI, Allison</creatorcontrib><creatorcontrib>MORJANA, Nihmat</creatorcontrib><creatorcontrib>MAREEVA, Tatiana</creatorcontrib><creatorcontrib>BEDZYK, William</creatorcontrib><creatorcontrib>SHARMA, Manoj</creatorcontrib><creatorcontrib>YAU, Heungyeung</creatorcontrib><creatorcontrib>ZHENG, Yi Feng</creatorcontrib><title>ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF</title><description>Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disclosed are methods of reducing naloxone or naltrexone interference in opiate assays using the antibodies. L'invention concerne des anticorps qui se lient spécifiquement à la naloxone ou à la naltrexone. L'invention concerne également des conjugués utilisés dans la production des anticorps, ainsi que des procédés de production des anticorps. L'invention concerne de plus des procédés d'utilisation des anticorps dans des dosages directs pour la naloxone ou la naltrexone. L'invention concerne en outre des procédés de réduction de l'interférence de la naloxone ou de la naltrexone dans des dosages d'opiacés à l'aide des anticorps.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAUALM4iPoPAedCWkHoGJMXEmjzJHmlbiVInEQL9f9Rgu5OB3e3Zkl6cpWXHV7QA5de85-hAMX16FF1-DElnVA7iOXsgSzqyNHwc0A9KHLoSxkicLIQAM2WrW7pvuTdlxu2N0DKVnl-TnmZ0zU_8msasRGNqI-ibltZH_673oqYNKE</recordid><startdate>20200806</startdate><enddate>20200806</enddate><creator>TENG, Zhu</creator><creator>DRAGHICI, Bogdan</creator><creator>LEBEDEVA, Tatiana</creator><creator>SMIRNOV, Yuriy</creator><creator>DOMINOWSKI, Allison</creator><creator>MORJANA, Nihmat</creator><creator>MAREEVA, Tatiana</creator><creator>BEDZYK, William</creator><creator>SHARMA, Manoj</creator><creator>YAU, Heungyeung</creator><creator>ZHENG, Yi Feng</creator><scope>EVB</scope></search><sort><creationdate>20200806</creationdate><title>ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF</title><author>TENG, Zhu ; DRAGHICI, Bogdan ; LEBEDEVA, Tatiana ; SMIRNOV, Yuriy ; DOMINOWSKI, Allison ; MORJANA, Nihmat ; MAREEVA, Tatiana ; BEDZYK, William ; SHARMA, Manoj ; YAU, Heungyeung ; ZHENG, Yi Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2020160199A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>TENG, Zhu</creatorcontrib><creatorcontrib>DRAGHICI, Bogdan</creatorcontrib><creatorcontrib>LEBEDEVA, Tatiana</creatorcontrib><creatorcontrib>SMIRNOV, Yuriy</creatorcontrib><creatorcontrib>DOMINOWSKI, Allison</creatorcontrib><creatorcontrib>MORJANA, Nihmat</creatorcontrib><creatorcontrib>MAREEVA, Tatiana</creatorcontrib><creatorcontrib>BEDZYK, William</creatorcontrib><creatorcontrib>SHARMA, Manoj</creatorcontrib><creatorcontrib>YAU, Heungyeung</creatorcontrib><creatorcontrib>ZHENG, Yi Feng</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TENG, Zhu</au><au>DRAGHICI, Bogdan</au><au>LEBEDEVA, Tatiana</au><au>SMIRNOV, Yuriy</au><au>DOMINOWSKI, Allison</au><au>MORJANA, Nihmat</au><au>MAREEVA, Tatiana</au><au>BEDZYK, William</au><au>SHARMA, Manoj</au><au>YAU, Heungyeung</au><au>ZHENG, Yi Feng</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF</title><date>2020-08-06</date><risdate>2020</risdate><abstract>Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disclosed are methods of reducing naloxone or naltrexone interference in opiate assays using the antibodies. L'invention concerne des anticorps qui se lient spécifiquement à la naloxone ou à la naltrexone. L'invention concerne également des conjugués utilisés dans la production des anticorps, ainsi que des procédés de production des anticorps. L'invention concerne de plus des procédés d'utilisation des anticorps dans des dosages directs pour la naloxone ou la naltrexone. L'invention concerne en outre des procédés de réduction de l'interférence de la naloxone ou de la naltrexone dans des dosages d'opiacés à l'aide des anticorps.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2020160199A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
title ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A10%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TENG,%20Zhu&rft.date=2020-08-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2020160199A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true